Introduction {#s1}
============

As individuals wait longer to have families, reproductive senescence has become an increasingly prudent topic ([@bib47]; [@bib38]). Decline in oocyte quality is well-documented with age and can result in fertility issues when older couples try to conceive ([@bib6]). Furthermore, pregnancies at an older age pose risks for higher incidences of birth defects and miscarriages. In humans, female reproduction ceases at an average age of 41--60, with the onset of menopause ([@bib67]). The *Caenorhabditis elegans* 'wild type' is hermaphroditic and self-fertilizing; however, they are capable of making and maintaining Mendelian ratios of male (sperm-only) animals in their populations. Like humans, *C. elegans* experience a decline in fecundity with age by halting oocyte production at roughly one-third of their lifespan ([@bib30]). In addition, regulators of reproductive aging, such as insulin/IGF-1 and *sma-*2/TGF-β signaling, are conserved regulators of reproductive aging from worms to humans ([@bib43]). While the majority of studies in reproductive senescence have focused on maternal effects, male factors contribute to a large portion of fertility complications with increasing evidence of an inverse relationship between paternal age and sperm health ([@bib38]). In fact, studies in mammals have shown an age-related decline in sperm quality with increased incidences of DNA damage, reduced motility, abnormal morphology, and decreased semen volume ([@bib15]; [@bib31]; [@bib51]).

Flavin adenine dinucleotide (FAD) is an important cofactor that participates in enzymatic redox reactions that are used in cellular metabolism and homeostasis. FAD is synthesized from riboflavin by the concerted actions of FAD synthetase and riboflavin kinase. Like humans, *C. elegans* cannot synthesize riboflavin, and therefore requires dietary intake ([@bib10]). Disruption of flavin homeostasis in humans and animal models has been associated with several diseases, including: cardiovascular diseases, cancer, anemia, abnormal fetal development, and neuromuscular and neurological disorders ([@bib7]); however, the link between FAD homeostasis and fertility is undefined.

We demonstrate that, although reproductive senescence is generally studied only from the female viewpoint, age-speciﬁc female reproductive success strongly depends on male--female interactions. Thus, a reduction in male fertilization efﬁciency with increasing age has detrimental consequences for female ﬁtness. Lastly, we call for investigations of the role of environmental conditions on reproductive senescence, which could provide salient insights into the underlying sex-speciﬁc mechanisms of reproductive success.

Several studies have documented fertility defects in *C. elegans* mitochondrial mutants. Mutation in *nuo-1*, a complex I component of the mitochondria respiratory chain, results in reduced brood size caused by impaired germline development ([@bib23]). Similarly, *clk-1* mutation affects the timing of egg laying, resulting in reduced brood size ([@bib29]). Both of these mitochondrial mutations impact fertility, but their role(s) in spermatogenesis are unclear. *alh-6*, the *C. elegans* ortholog of human *ALDH4A1*, is a nuclear-encoded mitochondrial enzyme that functions in the second step of the proline metabolism pathway, converting 1-pyrroline-5-carboxylate (P5C) to glutamate ([@bib1]). We previously revealed that *alh-6(lax105)* loss-of-function mutants display altered mitochondrial structure in the muscle accompanied by increased level of ROS in adult animals ([@bib55]). Furthermore, mutation in *alh-6* results in the activation of SKN-1/NRF2 ([@bib54]), an established regulator of oxidative stress response, likely through the accumulation of toxic P5C disrupting mitochondrial homeostasis ([@bib55]; [@bib54]; [@bib19]; [@bib46]; [@bib50]). Interestingly, SKN-1 was recently shown to respond to accumulation of damaged mitochondria by inducing their biogenesis and degradation through autophagy ([@bib53]). Here, we identify a genetic pathway that regulates male reproductive decline stemming from the perturbation of mitochondrial proline metabolism leading to redox imbalance, cofactor depletion, and altered mitochondria dynamics; all of which play a role in sperm dysfunction.

Results {#s2}
=======

Mutation in mitochondrial *alh-6* results in diet-independent reduction in fertility {#s2-1}
------------------------------------------------------------------------------------

Altered mitochondrial structure and activity have been correlated with sperm dysfunction across different species ([@bib39]; [@bib3]; [@bib57]; [@bib48]). In addition, proper sperm function requires low levels of ROS ([@bib18]; [@bib33]; [@bib37]), although a specific role for endogenous mitochondrial derived ROS is undefined. ALH-6/ALDH4A1, is a nuclear-encoded mitochondrial enzyme that functions in the second step of proline catabolism, converting 1-pyrroline-5-carboxylate (P5C) to glutamate ([Figure 1A](#fig1){ref-type="fig"}). We anticipated that mutation of *alh-6* may affect the germline, based on our previous assessment of the premature aging phenotypes in somatic cells of *alh-6* mutants ([@bib55]). Using an UV-integrated *alh-6::gfp* strain under its endogenous promoter, we saw that ALH-6 localizes to the mitochondria in the germline of both hermaphrodites and males ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We then assessed progeny output of *alh-6(lax105)* hermaphrodites fed the standard OP50/*E. coli* B strain diet and found a reduction in self-fertility brood size (−12.9%) ([Figure 1B](#fig1){ref-type="fig"}). Since the somatic phenotypes of *alh-6(lax105)* mutants are known to be diet-dependent ([@bib54]; [@bib55]), we examined self-fertility of animals fed the HT115/*E. coli* K-12 strain diet to determine if the reduced reproductive output is also dependent on the type of bacterial diet ingested. Surprisingly, we found that the self-fertility of *alh-6* animals was markedly reduced (−20.7%), when animals were fed the HT115 diet ([Figure 1C](#fig1){ref-type="fig"}). *alh-6* mutants have similar timing in their progeny output as compared to wild type animals on both diets ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Since *alh-6* mutants display normal development and reproductive timing, the progeny deficit is not a result of an attenuated reproductive span which reveals the differential impact of *alh-6* loss in the soma (diet-dependent) ([@bib55]) and the germline (diet-independent).

![*alh-6* fertility defects are sperm-specific.\
(**A**) Proline catabolism pathway. (**B--C**) *alh-6* hermaphrodites have reduced brood size when fed OP50 (**B**) or HT115 (**C**) diets. (**D**) *alh-6* hermaphrodites lay increased number of unfertilized oocytes, but few dead embryos. (**E**) Mated reproductive assay scheme utilizes males to maximize reproductive output (as in F) and can exploit males harboring GFP to differentiate progeny resulting from self- versus male-sperm (as in G). (**F**) Wild type (WT) and *alh-6* hermaphrodites mated with WT males yield similar number of total progeny. (**G**) WT hermaphrodites mated with *alh-6;gst-4p::gfp* males yield more non-GFP progeny (indicating self-fertilization) than hermaphrodites mated with WT males harboring *gst-4p::gfp*. Statistical comparisons by unpaired t-test. \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001. All studies performed in at least biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig1){#fig1}

We noted that *alh-6* mutant hermaphrodite animals laid twice as many unfertilized oocytes as wild type animals over their reproductive-span ([Figure 1D](#fig1){ref-type="fig"}), suggesting an impairment of sperm function ([@bib45]; [@bib73]; [@bib5]). It is notable that *alh-6* mutant hermaphrodites lay very few, if any, dead eggs ([Figure 1D](#fig1){ref-type="fig"}), suggesting that the loss of ALH-6 activity is not lethal. To determine whether the reduced brood size of *alh-6* mutants are due to a general loss of germ cells or a specific defect in oocytes or sperm, we examined the mated-fertility of these animals by mating wild type young adult (day 0--1) males to either wildtype or *alh-6* mutant virgin hermaphrodites (in wild type *C. elegans*, male sperm outcompetes hermaphrodite sperm \>99% of the time ([@bib72]; [@bib34]; [Figure 1E](#fig1){ref-type="fig"}). We found that the reduced fertility in *alh-6* mutant hermaphrodites is fully rescued by wild type sperm, which confirmed that oocyte quality is not impaired but rather, *alh-6* hermaphrodite sperm appears to be dysfunctional ([Figure 1F](#fig1){ref-type="fig"}).

To better assess the quality of *alh-6* mutant sperm, we compared the ability of *alh-6* mutant male sperm to compete against wild type hermaphrodite sperm ([@bib62]). In *C. elegans* wild type animals, male sperm are larger and faster than hermaphrodite sperm, which affords a competitive advantage ([@bib35]). To differentiate between progeny resulting from mating and progeny that arise from hermaphrodite self-fertilization, we made use of male animals harboring a GFP transgene such that any cross-progeny will express GFP while progeny that arise from hermaphrodite self-sperm will not ([Figure 1E](#fig1){ref-type="fig"}). We found that wild type hermaphrodites when mated to *alh-6* mutant males have significantly more self-sperm-derived progeny as compared to those mated to wild type males ([Figure 1G](#fig1){ref-type="fig"}). This finding indicates a competition deficit of *alh-6* male sperm resulting in this increased proportion of progeny derived from hermaphrodite sperm, which is uncommon after mating has occurred ([@bib72]). *C. elegans* hermaphrodites produce a set amount of sperm exclusively at the L4 developmental stage, before switching exclusively to oogenesis. As such, hermaphrodites eventually deplete their reservoir of sperm ([@bib27]; [@bib72]). To assess whether *alh-6* mutant sperm are generally dysfunctional, we mated older hermaphrodites that had depleted their complement of self-sperm and found that *alh-6* mutant males are able to produce equal numbers of progeny as wild type males when the need for competition with hermaphrodite sperm is abated ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}); thus, although *alh-6* mutant sperm are impaired for competition, they remain viable for reproduction. Similarly, older sperm-depleted *alh-6* mutant hermaphrodites produced similar brood sizes when mated to young wild type or *alh-6* mutant males, which further supports a model where sperm, but not oocytes, are defective in *alh-6* mutants ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). Taken together, these data suggest that while *alh-6* mutant male sperm remain competent for fertilization, their competitive advantage is impaired when challenged against hermaphrodite sperm.

Defects in mitochondrial proline catabolism impact sperm quality {#s2-2}
----------------------------------------------------------------

Similar to mammals, the contribution of sperm to fertility in *C. elegans* is dictated by distinct functional qualities, which include: sperm number, size, and motility ([@bib73]; [@bib36]; [@bib35]; [@bib62]). We next sought to define the nature of the sperm competition defect in *alh-6* mutants by measuring sperm number, size, and motility in *alh-6* mutants compared to wild type animals. One day after the onset of spermatogenesis (at the L4 larval stage of development), *alh-6* adult hermaphrodites have a reduced number of sperm in the spermatheca as compared to wild type ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), which is correlated with the reduced self-fertility observed ([Figure 1B--C](#fig1){ref-type="fig"}). In contrast, age-matched *alh-6* mutant virgin males have similar numbers of spermatids as WT virgin males, suggesting that they have a similar rate of production ([Figure 2A](#fig2){ref-type="fig"}). We next examined sperm size in day one adult males and discovered that *alh-6* mutant spermatids are significantly smaller as compared to wild type ([Figure 2B](#fig2){ref-type="fig"}). To achieve motility, *C. elegans* spermatids must form a pseudopod which requires protease activation ([@bib71]; [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Sperm activation can be recapitulated in vitro by treatment of isolated spermatids with the *Streptomyces griseus* protease Pronase ([@bib60]). After 30 min of Pronase treatment, 80% of wildtype spermatids are fully activated, while a significantly reduced population of *alh-6* mutant spermatids mature over the same time period ([Figure 2C](#fig2){ref-type="fig"}). The reduction in activation, as measured by the presence of a fully extended pseudopod, in *alh-6* mutant spermatids is correlated with an increase in the number of cells observed at the normally transient intermediate stage of spermiogenesis characterized by the presence of 'spikes' ([Figure 2---figure supplement 1B--C](#fig2s1){ref-type="fig"}; [@bib60]). We observed a similar impairment in activation of *alh-6* mutant spermatids when treated with the cationic ionophore Monensin ([Figure 2---figure supplement 1D--E](#fig2s1){ref-type="fig"}), except that *alh-6* mutant spermatids were stalled at the 'protrusion' intermediate stage of spermiogenesis ([@bib49]). Future studies to reveal where and how mitochondrial proline catabolism integrates into specific stages of spermiogenesis will be of great interest ([@bib60]).

![*alh-6* males have sperm defects on both OP50 and HT115 diets.\
(**A--C**) sperm phenotypes on OP50 diet. (**A**) Sperm quantity is similar between wild type (WT) and *alh-6* mutant day one adult males. (**B**) Spermatid size is reduced in *alh-6* mutant day one adult males as compared to age matched WT males. (**C**) Sperm activation is impaired in *alh-6* mutant day one adult males relative to age-matched WT males. (**D--F**) sperm phenotypes on HT115 diet. (**D**) Sperm quantity is reduced in *alh-6* mutant day one adult males compared to age-matched WT males. (**E**) Spermatid size is reduced in *alh-6* mutant day one adult males as compared to age matched WT males fed HT115. (**F**) Sperm activation is impaired in *alh-6* mutant day one adult males relative to age-matched WT males fed HT115. Statistical comparisons of sperm number and size by unpaired t-test and sperm activation by Fisher's exact test. \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001. All studies performed in at least biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig2){#fig2}

Interestingly, although sperm number was the same between WT and *alh-6* mutant males on the OP50 diet, sperm number was reduced in *alh-6* mutant males fed HT115 diet compared to age-matched WT males on the same diet ([Figure 2D](#fig2){ref-type="fig"}). We also noted that spermatids from *alh-6* mutant males raised on the HT115 diet were similarly defective in size and activation ([Figure 2E--F](#fig2){ref-type="fig"}). Taken together, although diet can influence sperm number, the reduction of sperm size and activation are likely contributors to the reduced fertility and competitive fitness in *alh-6* mutant males; which is independent of diet.

Transcriptional signatures define temporal phenotypes of *alh-6* mutant animals {#s2-3}
-------------------------------------------------------------------------------

We first identified *alh-6* mutant in a screen for activators of the cytoprotective transcription factor SKN-1/NRF2 using *gst-4p::gfp* as a reporter ([@bib55]; [@bib54]). When activated, SKN-1 transcribes a variety of gene targets that collectively act to restore cellular homeostasis. However, this can come with an energetic cost with pleiotropic consequences ([@bib9]; [@bib52]; [@bib21]; [@bib4]; [@bib44]; [@bib53]; [@bib54]; [@bib55]). *alh-6* mutants have normal development, but display progeroid phenotypes towards the end of the normal reproductive span ([@bib55]) indicating a temporal switch in phenotypic outcomes. We reasoned that the temporally controlled phenotypes in the *alh-6* mutants could be leveraged to identify potential mechanisms by which *alh-6* loss drives cellular dysfunction. As SKN-1 is activated in *alh-6* mutants after day 2 of adulthood ([@bib55]), we defined genes that display differentially altered expression in the L4 developmental stage, when spermatogenesis occurs, as compared to day three adults (post SKN-1 activation). We performed RNA-Seq analyses of worms with loss of *alh-6* and identified 1935 genes in L4 stage animals and 456 genes in day three adult animals that are differentially expressed (+/- Log~2~ (fold change), 0.05 FDR) ([Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}). Notably, the gene expression changes at these two life periods had distinct transcriptional signatures ([Figure 3A--B](#fig3){ref-type="fig"}). Because the loss of *alh-6* drives compensatory changes in normal cellular metabolism, which later in life results in the activation of SKN-1, we expected to identify significant changes in both metabolic genes and SKN-1 target genes. Supporting this hypothesis, the Gene Ontology (GO) terms most enriched include oxidoreductases and metabolic enzymes in L4 stage animals ([Figure 3A](#fig3){ref-type="fig"}) and SKN-1-dependent targets such as glutathione metabolism pathway genes in day three adults ([Figure 3B](#fig3){ref-type="fig"}). Importantly, our transcriptomic analysis recapitulated the temporally-dependent phenotypic outcomes resulting from *alh-6* loss; genes in the pseudopodium and germ plasm GO terms class displayed reduced expression in L4 *alh-6* mutant animals ([Figure 3A](#fig3){ref-type="fig"}), which include many genes in the major sperm protein (MSP) family that comprises 15% of total protein content in *C. elegans* sperm and impact sperm function ([@bib32]). In contrast, genes in the muscle-specific GO term class displayed increased expression in day three adults ([Figure 3B](#fig3){ref-type="fig"}), which is when activation of the SKN-1 reporter is enhanced in the muscle of *alh-6* mutants ([@bib54]). Taken together, the transcriptomic analysis of *alh-6* mutants is diagnostically relevant and informative for defining drivers of organism-level phenotypic changes in animals with altered proline catabolism.

![Transcriptional patterns define developmental- and adult-specific consequences to loss of *alh-6* activity.\
Gene Ontology (GO) term enrichment analysis of RNA-Seq data. (**A**) Transcriptional changes at L4 stage are enriched for metabolism and sperm-specific genes. (**B**) Transcriptional changes at day three adulthood are enriched for changes in glutathione activity, oxidoreductase activity, and muscle-specific genes. All studies performed in at least biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig3){#fig3}

FAD mediates sperm functionality and competitive fitness {#s2-4}
--------------------------------------------------------

The strong enrichment of genes whose protein products utilize and/or bind cofactors or co-enzymes was intriguing as the maintenance of metabolic homeostasis and the redox state of the cell requires a sophisticated balance of multiple cofactors ([Figure 4A](#fig4){ref-type="fig"}). In fact, the proline catabolism pathway utilizes multiple cofactors to generate glutamate from proline; PRDH-1 uses FAD as a co-factor to convert proline to P5C while ALH-6 utilizes the reduction of NAD+ to convert P5C to glutamate. Additionally, in the absence of ALH-6, accumulation of P5C, the toxic metabolic intermediate of proline catabolism, drives the expression of pathways to detoxify P5C (oxidoreductases, P5C reductase, etc.) ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Although enzymes in the proline catabolism pathway utilize FAD as a cofactor, the transcriptional signature of the *alh-6* mutants includes the activation of multiple enzymes that utilize FAD, which drove the hypothesis that FAD levels might be altered in *alh-6* mutants. We measured FAD and found a significant reduction in *alh-6* mutant animals fed the OP50 diet at the L4 stage ([Figure 4B](#fig4){ref-type="fig"}) and a similar reduction in animals fed HT115 bacteria at L4 stage ([Figure 4C](#fig4){ref-type="fig"}). Differences in FAD levels were unremarkable in day three adult animals, when spermatogenesis has long since ended ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Based on this finding, we predicted that restoration of FAD levels might alleviate the sperm-specific phenotypes of *alh-6* mutants. Riboflavin is a precursor of FAD ([Figure 4D](#fig4){ref-type="fig"}) and dietary supplementation of riboflavin has been shown to increase cellular FAD levels in wild-type animals ([@bib12]; [@bib59]). Similarly, riboflavin supplementation to the OP50 diet of *alh-6* mutants restored FAD levels to wild-type levels ([Figure 4E](#fig4){ref-type="fig"}). We found that wild type hermaphrodites mated to *alh-6* mutant males fed a riboflavin supplemented diet produced significantly more total progeny than *alh-6* males fed the standard OP50 diet ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Moreover, riboflavin supplementation was sufficient to partially restore male sperm size ([Figure 4F](#fig4){ref-type="fig"}) and also rescued the impaired activation ([Figure 4G](#fig4){ref-type="fig"}) of male sperm in *alh-6* mutants. Riboflavin supplementation increases sperm size in WT males, but do not change sperm activation in WT males ([Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}).

![Loss of FAD homeostasis in *alh-6* mutants leads to sperm dysfunction.\
(**A**) Metabolic pathways utilize adenine dinucleotide cofactors to maintain redox balance in cells. (**B--C**) FAD+ levels are reduced in *alh-6* mutant animals fed OP50 (**B**) or HT115 (**C**) at the L4 developmental stage. (**D**) FAD biosynthetic pathway. (**E--G**) Dietary supplement of riboflavin restores FAD level (**E**), sperm size (**F**), and sperm activation (**G**) in *alh-6* mutants. (**H--I**) RNAi knockdown of *R10H10.*6 (**H**) or *flad-1* (**I**) in WT males reduces their sperm size compared to L4440 vector control. (**J--K**) RNAi knockdown of *R10H10.6* (**J**) or *flad-1* (**K**) in WT males impairs sperm activation upon Pronase treatment. Statistical comparisons of sperm size by ANOVA. Statistical comparisons of activation by fisher's exact test with p-value cut-off adjusted by number of comparisons. \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001. All studies performed in biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig4){#fig4}

We next asked whether FAD metabolism was required for proper sperm function. FAD can be synthesized de novo by a two-step enzymatic reaction where riboflavin is converted to FMN by Riboflavin Kinase/R10H10.6, which is subsequently converted to FAD by FAD Synthase/FLAD-1 ([Figure 4D](#fig4){ref-type="fig"}). We used RNA interference (RNAi) against *R10H10.6* or *flad-1* in wild-type male animals and measured sperm quality. Similar to *alh-6* mutant sperm, RNAi reduction of the FAD biosynthetic pathway decreased sperm size ([Figure 4H and I](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1E--F](#fig4s1){ref-type="fig"}) and impaired sperm activation ([Figure 4J and K](#fig4){ref-type="fig"}, Figures [Figure 4---figure supplement 1E--F](#fig4s1){ref-type="fig"}).

NAD+ and NADH are also central adenine dinucleotide cofactors that play critical roles in metabolism and have received recent attention as a method to combat the decline seen in biological function with age ([@bib25]). As such, we also measured NAD and NADH levels, but found the ratio unremarkable between wild-type and *alh-6* mutant animals ([Figure 4---figure supplement 1G--I](#fig4s1){ref-type="fig"}). Taken together, these data suggest that loss of *alh-6* leads to a specific decrease in cellular FAD levels and that FAD is a critical cofactor that drives proper sperm function.

Mitochondrial dynamics regulate spermatid function {#s2-5}
--------------------------------------------------

Although there is a clear and documented role for mitophagy in the clearance of paternal mitochondria post-fertilization in *C. elegans*, the role(s) for mitochondrial dynamics and turnover in sperm function prior to zygote formation are unclear. We first examined mitochondrial dynamics in wild type spermatids by staining with the fluorescent mitochondrial-specific dye JC-1, and noted that each spermatid on average contained multiple discernable spherical mitochondria that are mostly not fused ([Figure 5A, B and E](#fig5){ref-type="fig"}). Previous studies in yeast and cultured mammalian cells have shown that when cells are exposed to mild stress, the initial response of mitochondria is to fuse in order to dilute damage ([@bib66]; [@bib22]; [@bib58]).

![Mitochondrial dynamics drive sperm quality.\
(**A--E**) JC-1 dye stained mitochondria of WT (**A--B**), *alh-6* mutant (**C--D**); (**B and D**) are ImageJ detection of JC-1 stained sperm mitochondria area which are quantified in (**E**). (**F**) Mitochondria in *alh-6* mutant spermatids have reduced JC-1 red/green fluorescence ratio, indicating mitochondria depolarization. (**G--H**) RNAi knockdown of FAD biosynthetic pathway genes, *R10H10.6* (**G**) or *flad-*1 (**H**) increases mitochondrial fusion in WT spermatids. (**I**) Dietary supplement of FAD precursor riboflavin restores mitochondrial fusion in *alh-6* spermatids to WT level. (**J--K**) *eat-3* or *fzo-1* RNAi decreases mitochondrial fusion in both WT (**J**) and *alh-6* (**K**) mutant spermatids. (**L**) *drp-1* mutation increases mitochondrial fusion in both WT and *alh-6* spermatids. (**M**) *drp-1* mutation significantly impairs sperm activation in both WT and *alh-6* mutant spermatids. (**N**) *fzo-1* RNAi restores sperm activation in *alh-6* mutant. (**O**) *eat-3* RNAi reduces sperm activation in WT males but not *alh-6* males. Statistical comparisons of JC-1 Red/Green FL ratio by unpaired t-test. Statistical comparisons of mitochondria fusion by ANOVA. Statistical comparisons of sperm activation by Fisher's exact test with p-value cut-off adjusted by number of comparisons. \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001. All studies performed in at least biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig5){#fig5}

The mitochondrial specific dye JC-1 accumulates in mitochondria in a membrane potential-dependent manner, and as the concentration increases, its fluorescence switches from green to red emission. The accumulation of sufficient JC-1 molecules required for red emission is abolished by treatment with Carbonyl cyanide *m*-chlorophenyl hydrazone (CCCP), a chemical inhibitor of mitochondrial oxidative phosphorylation ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Therefore, a higher red-to-green fluorescence ratio in cells is indicative of healthier mitochondria species and as such, we characterized mitochondria with red JC-1 emission in our analyses of connectivity in spermatids. *alh-6* mutant spermatids have reduced red:green JC-1 fluorescence that indicates a lower mitochondrial membrane potential and an accumulation of unhealthy mitochondria ([Figure 5F](#fig5){ref-type="fig"}; [@bib63]). Moreover, *alh-6* mutant spermatids have mitochondria that were more interconnected ([Figure 5C--E](#fig5){ref-type="fig"}) as compared to wild type spermatids and a similar increase in connectivity was observed when mitochondria were visualized with the membrane potential-dependent mitochondrial dye Mitotracker Red CMXRos ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). The increase in fused mitochondria in spermatids was also present in animals fed the HT115 diet, which further supports a diet-independent role for *alh-6* in the germline ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}).

A connection between mitochondrial dynamics (fusion and fission) and FAD homeostasis has not been previously described. To understand this, we perturbed FAD biosynthesis pathway and then examined mitochondrial connectivity in spermatids. We first reduced FAD biosynthesis with RNAi targeting *R10H10.6* or *flad-1*, which resulted in more connected mitochondria that resembles the increased fusion in *alh-6* mutant spermatids that are under metabolic stress ([Figure 5G--H](#fig5){ref-type="fig"}, [Figure 4---figure supplement 1E--F](#fig4s1){ref-type="fig"}). In addition, increasing FAD levels by dietary supplementation of riboflavin, restored mitochondria in spermatids of *alh-6* animals to more wild-type-like distributions ([Figure 5I](#fig5){ref-type="fig"}), but did not change mitochondrial morphology in WT male spermatids ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). Thus, the reduction of FAD in *alh-6* mutants, alters mitochondrial dynamics to a more fused and less punctate state. Therefore, the homeostatic control of FAD level is critical to maintain proper mitochondrial dynamics in sperm.

The role of mitochondrial dynamics in the maturation of sperm has not been studied; however recent work has revealed that the mitochondrial fusion and fission machinery are important for the elimination of paternal mitochondria post-fertilization ([@bib70]). FZO-1 is required for proper fusion of the mitochondrial outer membrane while EAT-3/OPA1 regulates inner membrane fusion. In opposition to the activities of FZO-1 and EAT-3, DRP-1 is required for mitochondrial fission ([@bib64]; [@bib41]). The balance of this fusion and fission machinery in the upkeep of mitochondrial homeostasis allows cells to respond to changes in metabolic needs and external stress ([@bib68]; [@bib61]). RNAi of *fzo-1* or *eat-3* reduced mitochondrial fusion in wild-type male sperm ([Figure 5J](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}) and suppressed the enhanced fusion observed in *alh-6* mutant spermatid mitochondria ([Figure 5K](#fig5){ref-type="fig"}); indicating mitochondrial fusion of both membranes is active in spermatids with impaired proline catabolism. We next examined spermatids from *drp-1* mutant animals and observed a greater level of mitochondrial fusion as compared to wild type and *alh-6* mutant spermatids ([Figure 5L](#fig5){ref-type="fig"}). We also observed a synergistic level of mitochondrial fusion in spermatids derived from *alh-6; drp-1* double mutants. This finding is consistent with previous studies in yeast which reveal that defects in fusion can be compensated for by changes in the rates of fission and vice versa ([@bib61]; [@bib68]). In support of our model where mitochondrial dynamics act as a major driver of the sperm-specific defects in *alh-6* mutants, we discovered that loss of *drp-1*, which results in increased mitochondrial fusion (like that observed in *alh-6* mutants), also reduces sperm activation ([Figure 5M](#fig5){ref-type="fig"}). Moreover, reducing *fzo-1* or *eat-3* does not alter activation in wild type sperm, while *fzo-1* but not *eat-3* RNAi restores activation in *alh-6* sperm ([Figure 5N--O](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}), suggesting increased fusion mediated predominantly by *fzo-1* in *alh-6* sperm mitochondria is impairing proper function. We noted that *alh-6* mutant animals have an increased expression of *fzo-1* transcripts that is suggestive of a retrograde signaling response from the mitochondria ([Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}). Taken together, these data support a model where loss of mitochondrial proline catabolism induces mitochondrial stress, activating mitochondrial fusion, in order to dilute damage to preserve functional mitochondria at the cost of sperm function. These data also reveal a functional role for mitochondrial fusion and fission in spermatid development and sperm function.

*alh-6* and FAD are cell autonomous regulators of sperm function {#s2-6}
----------------------------------------------------------------

Signaling between germ and somatic cells can alter function in each cell type ([@bib20]; [@bib16]; [@bib24]; [@bib8]; [@bib40]; [@bib42]; [@bib28]). In light of the differences between somatic and germline phenotypes observed in *alh-6* mutant animals, we performed germline specific RNAi targeting *alh-6* to deduce whether the sperm defects observed were cell autonomous. Germline specific RNAi of *alh-6* in wild-type males was not sufficient to alter sperm size ([Figure 6A](#fig6){ref-type="fig"}), but did result in diminished sperm activation ([Figure 6B](#fig6){ref-type="fig"},) and increased mitochondrial fusion in sperm ([Figure 6C](#fig6){ref-type="fig"}). Similarly, RNAi of *alh-6* only in the soma resulted in a minor reduction of spermatid size ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), but did not phenocopy the impairment of sperm activation as observed in *alh-6* mutants ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Taken together, these findings suggest that somatic expression of *alh-6* can influence spermatid size while the influence of *alh-6* on spermatid activation is cell autonomous.

![*alh-6* and FAD function cell autonomously in the germline to regulate sperm function.\
(**A--C**) Germline-specific RNAi of *alh-6* does not change sperm size (**A**), but does impair sperm activation (**B**) and increases mitochondrial fusion in sperm (**C**). (**D--F**) Germline-specific rescue of WT *alh-6* in *alh-6* mutant male animals increases sperm size (**D**) and restores activation (**E**) and mitochondrial dynamics (**F**). Statistical comparisons of sperm size and mitochondrial fusion in spermatids by unpaired t-test. Similarly, (**G--L**) germline-specific RNAi of *R10H10.6* and *flad-1* do not change sperm size (**G,J**), impair sperm activation (**H,K**), and increase mitochondrial fusion in sperm (**I,L**). Statistical comparisons of sperm activation by Fisher's exact test with p-value cut-off adjusted by number of comparisons. \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001. All studies performed in biological triplicate; refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"} for n for each comparison.](elife-52899-fig6){#fig6}

Next, we restored wild-type *alh-6* expression, only in the germline, in *alh-6* mutant animals, which restored sperm size in one of the two transgenic lines ([Figure 6D](#fig6){ref-type="fig"}), activation ([Figure 6E](#fig6){ref-type="fig"}) and mitochondrial dynamics ([Figure 6F](#fig6){ref-type="fig"}), as compared to non-transgenic siblings. We conclude that the effects of loss of *alh-6* on sperm function (activation and mitochondria) are cell autonomous because germline specific RNAi could phenocopy the sperm defects observed in whole animal loss of *alh-6*, while RNAi of *alh-6* only in the somatic tissues could not. In contrast, the effect of *alh-6* on sperm size is non-cell autonomous and requires somatic input ([Figure 6---figure supplement 1C--F](#fig6s1){ref-type="fig"}).

Since FAD functions in a variety of essential cellular processes, we next asked if proper sperm function required FAD homeostasis in germ cells. Similarly, we reduced *R10H10.6* or *flad-1* only in the germline, which phenocopies germline knockdown *of alh-6* on sperm size ([Figure 6G,J](#fig6){ref-type="fig"}), sperm activation ([Figure 6H,K](#fig6){ref-type="fig"}), and mitochondrial fusion in sperm ([Figure 6I,L](#fig6){ref-type="fig"}), as observed in whole animal RNAi of *flad-1* or *R10H10.6* ([Figure 4J--K](#fig4){ref-type="fig"} and [Figure 5G--H](#fig5){ref-type="fig"}).These results suggest that FAD functions similarly to *alh-6* in cell autonomously regulating sperm function (activation and mitochondrial dynamics), while affecting sperm size in a cell non-autonomous manner ([Figure 4H--I](#fig4){ref-type="fig"}). Taken together these data identify the importance of proline catabolism and FAD homeostasis in germ cells to maintain proper sperm function. In conclusion, our studies define mitochondrial proline catabolism as a critical metabolic pathway for male reproductive health.

Discussion {#s3}
==========

Here we investigate the effects of disrupting mitochondrial proline catabolism through the loss of the mitochondrial enzyme gene *alh-6* and the resulting changes in FAD homeostasis, mitochondrial dynamics, and male fertility ([Figure 7](#fig7){ref-type="fig"}). We found that *alh-6* mutants show a reduction in brood size that is sexually dimorphic; defects in sperm function but not oocytes contribute to reduced hermaphrodite fertility. As societal factors continue to push individuals to wait longer to have children, the increase in paternal age is inversely correlated with proper sperm function and can give rise to fertility issues. Consequently, it is incumbent on future studies to elucidate how restoring and maintaining functional amino acid catabolism during aging in order to promote reproductive success.

![Model of *alh-6* and FAD mediated male reproductive senescence.](elife-52899-fig7){#fig7}

Although *C. elegans* is a well-established organism for studying aging and reproduction, with several studies describing hermaphrodite reproductive senescence, many questions regarding the basis of male reproductive decline remain unanswered. Decades of work have shown that exposure to pollution, toxins, xenobiotics, and other ROS-inducing compounds can prematurely drive the loss of sperm function across species ([@bib2]; [@bib69]; [@bib14]), but the impact that normal cellular metabolism plays on sperm function and the identification of specific molecules that can mediate sperm quality are not well-defined. In this study we characterized a new role for mitochondrial proline catabolism and FAD homeostasis in the maintenance of proper sperm function. Perturbation of this pathway, through mutation of *alh-6/ALDH4A1*, causes metabolic stress. Consequently, this perturbation leads to reduction of cellular FAD level and increases mitochondrial fusion in spermatids, which results in impaired sperm function and premature reproductive senescence.

Mutation in proline dehydrogenase (*PRODH*) in humans results in hyperprolinemia type I (HPI), while mutation in delta-1-pyrroline-5-carboxylate dehydrogenase (*ALDH4A1/P5CDH*) results in hyperprolinemia type II (HPII). This study reveals that in *C. elegans*, proline catabolism impacts several functional qualities of male sperm. Loss of proline catabolism results in smaller sperm with impaired activation, two qualities that directly impact competitive advantage. As such, proline biosynthesis, catabolism, and steady state concentrations must be tightly regulated, and the importance of proline in cellular homeostasis may help explain the transcriptional responses measured in animals with dysfunctional *alh-6*. Our data support a cell autonomous role for proline catabolism in sperm. However, although whole animal RNAi of *alh-6* closely phenocopies the *alh-6* mutant including reduced spermatid size, germline specific RNAi of *alh-6* did not significantly reduce the size of spermatids; perhaps suggesting a partial role for ALH-6 in somatic tissues for spermatid development, which is in line with recent studies in *C. elegans* describing soma to germline signaling in sperm activation ([@bib13]). Intriguingly, the impact of loss of *alh-6* is mostly independent of diet source, unlike the somatic phenotypes which are diet-dependent ([@bib55]). The exception is sperm number in *alh-6* mutant animals on the HT115 diet, which appears to be diet-dependent ([Figure 2D](#fig2){ref-type="fig"}). WT males have more spermatids when fed the HT115 diet, as compared to WT animals fed OP50 diet, while *alh-6* mutants have the same number of spermatids on both diets.

Our previous work defined the age-dependent decline in function of somatic tissues, particularly muscle in animals lacking functional ALH-6 ([@bib55]; [@bib54]), which does not manifest until day 3 of adulthood. Our current study reveals that although somatic phenotypes in *alh-6* mutants are observed post-developmentally, the germline, or more specifically spermatids, are sensitive to loss of *alh-6* much earlier in development (phenotypes assayed at L4 or Day 1 of adulthood). Reproductive senescence is a field of growing significance as the number of couples that choose to delay having children increases. Importantly, although *alh-6* mutant sperm are impaired for competition, they remain viable for reproduction. This is similar to recent study on *comp-1,* a mutation which results in context-dependent competition deficit in *C. elegans* sperm ([@bib26]).

Recent studies have focused on the role of NAD+ metabolism in cellular health, while the impact of FAD has received less attention. FAD levels are diminished in *alh-6* animals specifically at the L4 stage when spermatogenesis is occurring. Riboflavin (Vitamin B~2~) is a precursor to the FAD and FMN cofactors that are needed for metabolic reactions in order to maintain proper cellular function, like proline catabolism and mitochondrial oxidative phosphorylation. Despite its importance, humans, like *C. elegans*, lack a riboflavin biosynthetic pathway and therefore require riboflavin from exogenous sources ([@bib56]). Insufficient intake can lead to impairment of flavin homeostasis, which is associated with cancer, cardiovascular diseases, anemia, neurological disorders, impaired fetal development, etc. ([@bib56]). Our study suggests that riboflavin and FAD play critical roles in reproduction, specifically in germ cell development, as loss of FAD biosynthesis or loss of *alh-6* specifically in the germline recapitulates the sperm defects observed in whole animal knockdown or *alh-6* mutation. Importantly, these sperm-specific defects can be corrected by dietary supplementation of vitamin B~2~, which in light of the exceptional conservation of mitochondrial homeostatic pathways, suggest the nutraceutical role vitamin B~2~ could play in sperm health across species.

Our study also demonstrates that spermatids lacking *alh-6* have increased mitochondrial fusion; a perturbation at the mitochondrial organelle structure-level that contributes to the sperm-specific phenotypes observed. In addition to prior work showing *fzo-1/MFN1/MFN2* and *drp-1*/*DRP-1* to be important for mitochondrial elimination post-fertilization ([@bib70]), our work reveals that mitochondrial fission and fusion machinery are present and active in spermatids and that perturbation of these dynamics can affect sperm maturation and competitive fitness. Future work to define how *alh-6* spermatids use mitophagy, which can clear damaged mitochondria, will be of interest. In conclusion, our work identifies proline metabolism as a major metabolic pathway that can impact sperm maturation and male reproductive success. Moreover, these studies identify specific interventions to reverse the redox imbalance, cofactor depletion, and altered mitochondria dynamics, all of which play a part in sperm dysfunction resulting from proline metabolism defects.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation                                Source or reference                                              Identifiers                                                    Additional\
  or resource                                                                                                                                                                                          information
  ------------------------- ------------------------------------------ ---------------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Strain (*C. elegans*)     N2                                         *Caenorhabditis* Genetics Center (CGG)                                                                                          Laboratory reference strain (wild type)

  Strain (*C. elegans*)     SPC321                                     PMID: [24440036](https://www.ncbi.nlm.nih.gov/pubmed/24440036)                                                                  Genotype: *alh-6(lax105)*

  Strain (*C. elegans*)     SPC326                                     PMID: [24440036](https://www.ncbi.nlm.nih.gov/pubmed/24440036)                                                                  *alh-6p::alh-6::gfp*

  Strain (*C. elegans*)     SPC447                                     This paper                                                                                                                      Genotype: *alh-6(lax105);laxEx025(pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)*

  Strain (*C. elegans*)     SPC455                                     This paper                                                                                                                      Genotype: *alh-6(lax105);laxEx033*(*pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)*

  Strain (*C. elegans*)     SPC473                                     This paper                                                                                                                      Genotype: *alh-6(lax105);laxEx051*(*pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)*

  Strain (*C. elegans*)     CL2166                                     *Caenorhabditis* Genetics Center (CGG)                                                                                          Genotype: *gst4-p::gfp*

  Strain (*C. elegans*)     SPC223                                     PMID: [24440036](https://www.ncbi.nlm.nih.gov/pubmed/24440036)                                                                  Genotype: *alh-6(lax105);gst-4p::gfp*

  Strain (*C. elegans*)     DCL569                                     *Caenorhabditis* Genetics Center (CGG)                                                                                          Genotype: \[*mkcSi13*(*sun-1p::rde-1::sun-1* 3\'UTR + *unc-119*(+)) II; *rde-1(mkc36)* V

  Strain (*C. elegans*)     CU6372                                     *Caenorhabditis* Genetics Center (CGG)                                                                                          Genotype: *drp-1(tm1108)*

  Strain (*C. elegans*)     GR1948                                     PMID: [24684932](https://www.ncbi.nlm.nih.gov/pubmed/24684932)                                                                  Genotype: *mut-14(mg464);smut-1(tm1301)* V.

  Chemical compound, drug   Riboflavin                                 Millipore Sigma                                                  R9504                                                          Concentration used: 2.5 mM

  Commercial Assay or kit   FAD Colorimetric/Fluorometric Assay Kit    BioVision                                                        K357                                                           

  Commercial Assay or kit   NAD/NADH Quantification Colorimetric Kit   BioVision                                                        K337                                                           

  Chemical compound, drug   Pronase                                    Millipore Sigma                                                  P8811                                                          Concentration used: 200 ug/mL

  Chemical compound, drug   eBioscience Monensin Solution (1000X)      Thermo Fisher Scientific                                         00-4505-51                                                     Concentration used: 100 nM

  Chemical compound, drug   MitoProbe JC-1 Assay Kit                   Thermo Fisher Scientific                                         M34152                                                         Concentration used: JC-1 15 uM, CCCP 50 uM

  Chemical compound, drug   MitoTracker Red CMXRos                     Thermo Fisher Scientific                                         M7512                                                          Concentration used:\
                                                                                                                                                                                                       100 uM dried on plate

  Software                  GraphPad Prism                             GraphPad Prism (<https://graphpad.com>)                          RRID:[SCR_015807](https://scicrunch.org/resolver/SCR_015807)   Version 6

  Software                  ImageJ                                     ImageJ (<http://imagej.nih.gov/ij/>)                             RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*C. elegans* strains and maintenance {#s4-1}
------------------------------------

*C. elegans* were cultured using standard techniques at 20°C. The following strains were used: wild type (WT) N2 Bristol, SPC321\[*alh-6(lax105)*\], SPC326\[*alh-6p::alh-6::gfp*\], SPC447\[*alh-6(lax105);laxEx025*(*pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)*\], SPC455\[*alh-6(lax105);laxEx033*(*pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)*\], SPC473\[*alh-6(lax105);laxEx051*(*pie-1p::alh-6;myo-2p::rfp;myo-3p::rfp;rab-3p::rfp)\]*\], CL2166\[*gst4-p::gfp*\], SPC223\[*alh-6(lax105);gst-4p::gfp*\], DCL569\[*mkcSi13*(*sun-1p::rde-1::sun-1* 3\'UTR + *unc-119*(+)) II; *rde-1(mkc36)* V\], CU6372\[*drp-1(tm1108)*\], and GR1948\[*mut-14(mg464);smut-1(tm1301)* V\]. Double and triple mutants were generated by standard genetic techniques. *E. coli* strains used were as follows: B Strain OP50 ([@bib11]) and HT115(DE3) \[F^-^mcrA mcrB IN(rrnD-rrnE)one lambda^-^ rnc14::Tn10 λ(DE3)\]([@bib65]). For dietary supplement assays, riboflavin was added to the NGM plate mix to final concentration 2.5 mM.

RNAi-based experiments {#s4-2}
----------------------

RNAi experiments were done using HT115-based RNAi ([@bib65]), which yielded similar results as OP50 RNAi *E. coli* B strain as described in [@bib17]. All strains were adapted to diets for at least three generations and strains were never allowed to starve. All RNAi clones were sequenced prior to use and RNAi knockdown efficiency measured. RNAi cultures were seeded on IPTG plates and allowed to induce overnight prior to dropping eggs on them for experiments.

Microscopy {#s4-3}
----------

Zeiss Axio Imager and ZEN software were used to acquire all images used in this study. For GFP reporter strains, worms were mounted in M9 with 10 mM levamisole and imaged with DIC and GFP filters. For sperm number, assay samples were imaged with DIC and DAPI filters in z-stacks. For sperm size and activation assays, dissected sperm samples were imaged at 100x with DIC filter on two different focal planes for each field to ensure accuracy. For sperm mitochondria assays, dissected sperm samples were imaged at 100x with DIC, GFP, and RFP filters in z-stacks to assess overall mitochondria content within each spermatid.

Fertility assay {#s4-4}
---------------

Worms were treated with alkaline hypochlorite and eggs were allowed to hatch overnight. The next day, synchronized L1 larvae were dropped on NGM plates seeded with either OP50 or HT115. 48 hr later, at least ten L4 hermaphrodites for each genotype were singled onto individual plates and moved every 12 hr until egg laying ceased. Progeny were counted 48 hr after the singled hermaphrodite was moved to a different plate. Plates were counted twice for accuracy.

Mated reproductive assay {#s4-5}
------------------------

Males were synchronized by egg laying, picked as L4 larvae for use as young adults for mating experiments. Singled L4 stage hermaphrodites were each put on a plate with 30 ul of OP50 seeded in the center together with three virgin adult males. 24 hr post-mating, males were removed, and each hermaphrodite was moved to a new plate every 24 hr until egg laying ceased. Progeny were counted 48 hr after the hermaphrodite was moved from the plate. For sperm competition assay, progeny with GFP fluorescence were counted from the cohort. Plates were counted twice for accuracy.

Cofactor measurements {#s4-6}
---------------------

Worms were treated with alkaline hypochlorite and eggs were allowed to hatch overnight. The next day, synchronized L1s were dropped on NGM plates with or without supplement seeded with 25X concentrated OP50. FAD levels are measured following directions in FAD Colorimetric/Fluorometric Assay Kit (K357) from BioVision. NAD/NADH levels are measured following directions in NAD/NADH Quantification Colorimetric Kit (K337).

Sperm number assay {#s4-7}
------------------

Worms were treated with alkaline hypochlorite and eggs were allowed to hatch overnight. The next day, synchronized L1s were dropped on NGM plates with the indicated food source. At 48 hr (L4 developmental stage) males were isolated to new plates. 72 hr post-drop, day one adult virgin male animals were washed 3x with 1xPBST, fixed with 40% 2-propanol, and stained with DAPI for 2 hr. Samples were washed for 30 min with PBST, mounted with Vectashield mounting medium, and covered with coverslip to image. Spermatids in the seminal vesicle were counted through all planes in z-stack.

Sperm size assay {#s4-8}
----------------

Males were isolated at L4 stage 24 hr before assay. For each strain, five day one adult males were dissected in 35 μL pH 7.8 SM buffer (50 mM HEPES, 50 mM NaCl, 25 mM KCl, 5 mM CaCl~2~, 1 mM MgSO~4~, 10 mM dextrose) to release spermatids, which were immediately imaged.

Sperm activation with pronase and monensin {#s4-9}
------------------------------------------

Males were isolated at L4 stage 24 hr before assay. For each strain, five day one adult males were dissected in 35 μL pH 7.8 SM buffer (50 mM HEPES, 50 mM NaCl, 25 mM KCl, 5 mM CaCl~2~, 1 mM MgSO~4~, 1 mg/ml BSA) supplemented with either 200 μg/mL Pronase (Millipore Sigma) or 100 nM Monensin (Thermo Fisher Scientific 00-4505-51) to release spermatids. Another 25 ul of the same solution was added and the spermatids were incubated at RT for 30 min for activation to occur before imaging.

Sperm mitochondria staining {#s4-10}
---------------------------

Males were isolated at L4 stage 24 hr before assay. For each strain, five day one adult males were dissected in 35 μL pH 7.8 SM buffer (50 mM HEPES, 50 mM NaCl, 25 mM KCl, 5 mM CaCl~2~, 1 mM MgSO~4~, 1 mg/ml BSA) with JC-1(Thermo Fisher Scientific M34152) added to 15 μM final concentration. Another 25 ul of the same solution was added and the spermatids were incubated at RT for 10 min. The slide was washed three times with 100 ul SM buffer before imaging. For carbonyl cyanide *m*-chlorophenyl hydrazine (CCCP) uncoupler control in JC-1 staining experiment, 50 uM final concentration was used in staining solution. For staining with MitoTracker Red CMXRos (Thermo Fisher Scientific M7512), stock solution was diluted to 100 uM final concentration in M9 and 50 ul of this solution was applied on top of a spot of 50 uL 25X concentrated OP50 seeded on a NGM plate. Solution was allowed to dry on the plate before L4 virgin males were moved onto the food spot. Animals were allowed to stain overnight (18--24 hr) and dissected next day in SM buffer for spermatids to image.

RNA-Sequencing {#s4-11}
--------------

Worms were egg prepped and eggs were allowed to hatch overnight. The next day, synchronized L1s were dropped on NGM plates seeded with 25X concentrated OP50. 48 and 120 hr post drop, L4 animals and day three adult animals, respectively, were washed three times with M9 and frozen in TRI Reagent at −80°C. Animals were homogenized and RNA extraction was performed following the protocol in Zymo Direct-zol RNA Isolation Kit. RNA samples were sequenced and analyzed by Novogene.

Statistical analysis {#s4-12}
--------------------

Data are presented as mean ± SEM. Comparisons and significance were analyzed in Graphpad Prism 7. Comparisons between two groups were done using Student's Test. Comparisons between more than two groups were done using ANOVA. For sperm activation assays, Fisher's Exact Test was used and p-values are adjusted for multiple comparisons. \*p\<0.05 \*\*p\<0.01 \*\*\*p\<0.001 \*\*\*\*\<0.0001.
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This study defines a cell autonomous role of mitochondria proline catabolism and FAD homeostasis in sperm functionality and competitive fitness. These interesting findings help us to understand how male sperm quality is controlled.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Loss of mitochondrial proline catabolism depletes FAD, impairing sperm function, and male reproductive advantage\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers agreed that the findings of this study, namely that a perturbation of mitochondrial proline catabolism impairs sperm quality and competitive fitness, are novel and interesting. However, this study falls short of providing mechanistic information to meet the standards for *eLife*. A substantial amount of work needs be conducted to address the concerns raised by the reviewers.

*Reviewer \#1:*

In this manuscript, Yen et al. found that perturbation of mitochondrial proline catabolism impairs sperm quality and competitive fitness. The authors showed that loss of function of *alh-6*, encoding a mitochondrial enzyme involved in proline metabolism, leads to oxidative stress, FAD depletion and excess mitochondrial fusion. These pleiotropic defects reduce sperm quality. This study defines a role of mitochondria proline catabolism and FAD homeostasis in sperm functionality and competitive fitness. Previous studies have proved the importance of mitochondrial activity and ROS in male sperm function. Altered mitochondrial structure and increased level of ROS in *alh-6* loss of function mutants has also been shown by the same group. In this study, the authors observed a correlation of FAD levels and ROS with spermatid size and activation. However, no mechanistic insights have been shown. Whether levels of FAD and ROS act autonomously in sperm or in other tissues to regulate sperm functionality has not been addressed. In general, this study fails to meet the stringent requirements for publication in *eLife*.

1\) The authors showed that levels of FAD are reduced in *alh-6* mutants. Levels of FAD in sperm could be determined.

2\) Addition of riboflavin or antioxidant NAC restores spermatid size and activation in *alh-6* mutants. Do they affect sperm function in wild type animals or in other sperm defective mutants? Do they act autonomously to regulate sperm function?

*Reviewer \#2:*

The paper by Yen et al. describes that loss of *alh-6* leads to P5C accumulation and FAD depletion, which impair sperm functions in *C. elegans*. The authors further found that blocking P5C generation, or supplement with FAD or NAC, or modulating mitochondrial dynamics restored sperm functions in *alh-6* mutants. These findings suggest a requirement for proper P5C catabolism in sperm quality control. Nevertheless, the causal effects of FAD depletion or P5C accumulation on ROS change and mitochondrial defects in the absence of *alh-6* need to be clarified for the paper to be considered for publication in *eLife*.

1\) The title needs to be reconsidered, because blocking the first step of proline catabolism by loss of *prdh-1* in fact suppressed the sperm defects in *alh-6* mutants.

2\) The RNA-seq data revealed genes that are likely involved in FAD binding (Figure 3), what are the effects on FAD, mitochondria, and sperm activities when these genes (17) are inactivated (in the backgrounds of WT and *alh-6*)?

3\) Is the reduction of FAD in *alh-6* mutants diet-specific? Does *alh-6* mutation influence NAD+ level? Does supplement with FAD rescue the mitochondrial defects (both somatic and sperm) in *alh-6* mutants? This could distinguish whether the decrease in FAD or accumulation of P5C drives mitochondrial and sperm defects.

4\) Is the FAD level restored to WT in *alh-6;prdh-1* double mutants? This is important to draw the conclusion that PRDH-1 continues to deplete FAD in the absence of *alh-6* (subsection "FAD mediates sperm functionality and competitive fitness").

5\) The subtitle \"loss of cellular proline catabolism is not causal for sperm defects in *alh-6* mutants\" needs to be reconsidered. It appears contradictory to the title of the manuscript.

6\) The authors proposed that accumulation of P5C could account for ROS change that leads to sperm defects in *alh-6* mutants. Experimental data should be provided on restoration of ROS levels by supplement with NAC and FAD.

7\) Are mitochondrial defects seen in *alh-6* sperms diet-specific? The authors showed that partial inactivation of *fzo-1* restored sperm activation, how about RNAi of *eat-3*? Does RNAi of *fzo-1* and *eat-3* change the ROS levels in *alh-6* mutant sperms?

8\) The current model (Figure 6N) failed to define the relationships of P5C accumulation, FAD depletion, ROS change, mitochondrial dynamics and sperm quality. A better model needs to be suggested.

\[Editors' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for submitting your article \"Loss of flavin adenine dinucleotide (FAD) impairs sperm function and male reproductive advantage in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The revision has much improved the manuscript. Please address the concerns raised by reviewers \#2 and \# 3, which are pretty straightforward.

Reviewer \#1:

My concerns raised in the initial round of reviewing process have been satisfactorily addressed. The authors provide new data to show that FAD acts autonomously in sperm to regulate sperm functionality. It is acceptable now.

Reviewer \#2:

The manuscript by Yen et al. reports that impairment of mitochondrial proline metabolism caused by loss of *alh-6* leads to reduction of FAD levels, alteration of mitochondrial dynamics in sperm, and age-related pleiotropic consequences on sperm size and activity. They further found that inactivation of *alh-6* or FAD synthesis genes in the germline is sufficient to recapitulate the sperm defects as in whole animals with *alh-6* loss of function. They suggest that mitochondrial proline metabolism and FAD homeostasis play a cell autonomous role to maintain sperm function. These findings are very interesting, especially, by revealing the requirement of FAD for mitochondrial dynamics and sperm function. The manuscript is greatly improved compared with the previous one.

1\) It is interesting that loss of ALH-6, but not PRDH-1 which uses FAD as cofactor, caused reduction of FAD levels. What are the possible biochemical explanations? Can this be experimentally tested?

2\) The authors performed germline-specific RNAi to inactivate *alh-6* and FAD synthesis genes, which induced sperm defects as in *alh-6* mutant animals. In addition, expression of ALH-6 in the germline rescued the sperm defects. Thus, the conclusion is drawn that the effects of *alh-6* loss on sperm function are cell autonomous. This seems not to be sufficient. Will overexpression of ALH-6 in somatic tissues, e.g., the intestine, rescue the sperm defect in *alh-6* mutants?

Reviewer \#3:

In this manuscript, Yen et al. found that loss of mitochondrial proline catabolism impairs sperm quality (size and activation) and male sperm competitiveness over hermaphrodite sperm. They showed that reduction of FAD levels lead to more mitochondria fusion, smaller sperm size, and less sperm activation by artificial sperm activator Pronase. In mature spermatids, both transcription and translation are quiescent, therefore, mitochondrial proline catabolism involved in the sperm quality control is very intriguing. It has been long known that male sperm size is larger, correlated with their superior competitiveness over hermaphrodite sperm during a regular crossing. This paper however does not provide a mechanistic insights about the link between the physical size of sperm and its mitochondrial proline catabolism, how FAD affects cell size.

1\) Though Pronase (a mixture of proteases which cleave any surface protein on the cell) could be used to assess wild type sperm activation, Monensin is a better artificial sperm activation as it can make activated spermatozoa to crawl. At least, the authors need to check at which step mutant sperm failed to activate. The crossing data (in vivo sperm activation in Figure 1F) are inconsistent to the rest mutant sperm activation data.

2\) JC-1 staining (Figure 5A-D) was employed extensively in this study to show the mitochondrial fusion or not. This reviewer suggests confirming that with a GFP-tagged mitochondrial protein such as TOM20 to avoid any bias for imaging collection and analysis.

3\) Figure 1---figure supplement 1D should use a better image instead of the current one.

10.7554/eLife.52899.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

> Reviewer \#1:
>
> In this manuscript, Yen et al. found that perturbation of mitochondrial proline catabolism impairs sperm quality and competitive fitness. The authors showed that loss of function of alh-6, encoding a mitochondrial enzyme involved in proline metabolism, leads to oxidative stress, FAD depletion and excess mitochondrial fusion. These pleiotropic defects reduce sperm quality. This study defines a role of mitochondria proline catabolism and FAD homeostasis in sperm functionality and competitive fitness. Previous studies have proved the importance of mitochondrial activity and ROS in male sperm function. Altered mitochondrial structure and increased level of ROS in alh-6 loss of function mutants has also been shown by the same group. In this study, the authors observed a correlation of FAD levels and ROS with spermatid size and activation. However, no mechanistic insights have been shown. Whether levels of FAD and ROS act autonomously in sperm or in other tissues to regulate sperm functionality has not been addressed. In general, this study fails to meet the stringent requirements for publication in eLife.

We appreciate this feedback. By using germline specific RNAi of FAD biosynthesis genes in combination with germline specific recue of *alh-6*, we have determined the cell autonomous nature of FAD loss and *alh-6* activity in germ cells (Figure 6A-L). The generation and validation of these transgenic and the subsequent analyses of all sperm quality assays are the reasons this resubmission took 10 months to complete. We agree that this was an essential piece of the story that was missing and greatly enhances our study.

> 1\) The authors showed that levels of FAD are reduced in alh-6 mutants. Levels of FAD in sperm could be determined.

We would love to measure FAD in sperm. However, the assays we used (we have tried several commercial kits) all require a minimum of 10^6^ and in some cases 10^8^ cells to meet sensitivity thresholds. Attaining this number of *C. elegans* spermatids while maintaining integrity of FAD is not possible; although we have tried to get close to this number and assay for FAD which was below detectable range. Similarly, measurements in dissected male gonads was also below detection limit.

As an alternative approach, we now show that reducing the expression of the FAD biosynthesis enzymes in germ cells phenocopies the sperm defects observed in the *alh-6* mutants.

Moreover, reducing *alh-6* expression only in germ cells, also recapitulates the sperm defects in *alh-6* mutants (Figure 6A-I).

We also show that the loss of *alh-6* does not affect NAD/NADH (Figure 4---figure supplement 1G-I), thus the effects on FAD are specific. Due to this specificity and novelty of FAD in affecting sperm function, we decided to focus on describing this mechanism in this manuscript.

> 2\) Addition of riboflavin or antioxidant NAC restores spermatid size and activation in alh-6 mutants. Do they affect sperm function in wild type animals or in other sperm defective mutants? Do they act autonomously to regulate sperm function?

We have tested the impact of NAC on WT sperm and we found that there were no changes, suggesting the effect of ROS on *alh-6* sperm defects is specific.

WT males fed riboflavin supplement have increased sperm size, but activation and mitochondrial distributions remain unchanged (new Figure 4---figure supplement 1C-D, Figure 5---figure supplement 1D). The rescue of all sperm defects in *alh-6* mutants with dietary riboflavin supplement suggests FAD reduction is causal to these defects (Figure 4E-G, Figure 5I).

The idea that riboflavin could act as a general therapeutic for defective sperm was intriguing. There are several sperm mutants in *C. elegans* with known defects in spermatogenesis. However, none of these mutants have known functions in mitochondrial metabolism. Nevertheless, we have tested *spe-10* mutant with NAC and riboflavin dietary supplements, both of which do not rescue its severe sperm activation defect. Although a negative result, we would be happy to include this data (see [Author response image 1](#respfig1){ref-type="fig"}, n = 40-80 individual spermatids) as it suggests that riboflavin treatment is specific to the sperm defects in *alh-6* mutants, supporting the causal role of reduced FAD.

![](elife-52899-resp-fig1){#respfig1}

> Reviewer \#2:
>
> The paper by Yen et al. describes that loss of alh-6 leads to P5C accumulation and FAD depletion, which impair sperm functions in *C. elegans*. The authors further found that blocking P5C generation, or supplement with FAD or NAC, or modulating mitochondrial dynamics restored sperm functions in alh-6 mutants. These findings suggest a requirement for proper P5C catabolism in sperm quality control. Nevertheless, the causal effects of FAD depletion or P5C accumulation on ROS change and mitochondrial defects in the absence of alh-6 need to be clarified for the paper to be considered for publication in eLife.

We agree! By using germline specific RNAi of FAD biosynthesis genes in combination with germline specific recue of *alh-6*, we have determined the cell autonomous nature of FAD loss and *alh-6* dependent roles in germ cells (new Figure 6A-L). We agree that this was an essential piece of the story that was missing.

> 1\) The title needs to be reconsidered, because blocking the first step of proline catabolism by loss of prdh-1 in fact suppressed the sperm defects in alh-6 mutants.

We agree that our title needed to be more accurate. Due to the specificity and novelty of FAD in affecting sperm function, we have decided to focus on describing this mechanism in this paper. As such, we have changed our title to emphasize the importance of FAD.

> 2\) The RNA-seq data revealed genes that are likely involved in FAD binding (Figure 3), what are the effects on FAD, mitochondria, and sperm activities when these genes (17) are inactivated (in the backgrounds of WT and alh-6)?

This is an interesting question. Inactivation of any one of these is unlikely to have an effect, but the combined actions of all is what likely results in the reduction of FAD level in *alh-6* animal at larval stage 4 when spermatogenesis occurs (Figure 4B-C).

We now show that germ cell-specific RNAi of FAD biosynthesis or germ cell-specific RNAi of *alh-6* drives similar activation impairment and altered mitochondrial dynamics as observed in the *alh-6* mutants (new Figure 6A-I). Moreover, restoring WT *alh-6* expression in the germline is sufficient to rescue sperm defects in *alh-6* mutants (new Figure 6J-L).

> 3\) Is the reduction of FAD in alh-6 mutants diet-specific? Does alh-6 mutation influence NAD+ level? Does supplement with FAD rescue the mitochondrial defects (both somatic and sperm) in alh-6 mutants? This could distinguish whether the decrease in FAD or accumulation of P5C drives mitochondrial and sperm defects.

These are great questions that we now clarify in our study. In the revised manuscript we include all data on HT115 and OP50 for all sperm phenotypes This data can be found in the following new figure panels:

-- Sperm number (Figure 2A and 2D)

-- Sperm size (Figure 2B and 2E)

-- Sperm activation (Figure 2C and 2F)

-- Sperm mitochondrial fusion (Figure 5E and Figure 5---figure supplement 1C)

-- FAD (Figure 4B-C)

The reduction of FAD biosynthesis pathway genes or *alh-6* in whole animal RNAi recapitulates all phenotypes. Germ cell specific RNAi of FAD biosynthesis pathway genes or *alh-6* recapitulated all sperm defects except sperm size (which seem to require some input from the somatic; discussion of this point is included). Riboflavin supplementation restores FAD level and suppresses all the sperm defects in the *alh-6* mutants (Figure 4E-G, Figure 5I).

> 4\) Is the FAD level restored to WT in alh-6;prdh-1 double mutants? This is important to draw the conclusion that PRDH-1 continues to deplete FAD in the absence of alh-6 (subsection "FAD mediates sperm functionality and competitive fitness").

Based on the previous review we have focused on *alh-6* and the changes in FAD as this is the novel aspect of our work.

As the reviewer is likely aware, P5C can be generated by ornithine and arginine metabolic pathways as well as proline catabolism. Although the *prdh-1* mutant would shed light on the latter there is evidence that homeostatic changes in these critical metabolic pathways occurs and we cannot rule out alterations to the urea cycle.

> 5\) The subtitle \"loss of cellular proline catabolism is not causal for sperm defects in alh-6 mutants\" needs to be reconsidered. It appears contradictory to the title of the manuscript.

We have focused our study on the novel aspects relating to the loss of ALH-6, specifically the changes in FAD and cell autonomous roles in sperm.

> 6\) The authors proposed that accumulation of P5C could account for ROS change that leads to sperm defects in alh-6 mutants. Experimental data should be provided on restoration of ROS levels by supplement with NAC and FAD.

Fixed and also refocused our study on FAD.

> 7\) Are mitochondrial defects seen in alh-6 sperms diet-specific? The authors showed that partial inactivation of fzo-1 restored sperm activation, how about RNAi of eat-3? Does RNAi of fzo-1 and eat-3 change the ROS levels in alh-6 mutant sperms?

This is an excellent question that we apologize for not making clear in the first submission. The mitochondrial defect in *alh-6* sperm is not diet-specific and is manifested in animals fed either the OP50/*E. coli* B or HT115/K-12 diet (Figure 5E and Figure 5---figure supplement 1C).

*fzo-1* RNAi rescued both mitochondrial and activation defects in *alh-6* spermatids, while *eat-3* RNAi rescued just the mitochondrial defect but not the activation defect (Figure 5J-K, N-O). The connections between inner and outer mitochondrial membrane dynamics is continually emerging. The increase in *fzo-1* expression in *alh-6* mutant together with these results suggest that the defects in *alh-6* clearly engage the FZO-1 pathway.

Unfortunately, we could not measure ROS in sperm, however we have assessed the literature and found that *eat-3* mutant is more sensitive to paraquat than WT but not *fzo-1* mutant. This increased sensitivity in *eat-3* suggests a mitochondrial fusion independent role in ROS homeostasis. Furthermore, *eat-3* mutants have other defects that are enhanced by sod-2 mutation (Kanazawa et al., 2008).

> 8\) The current model (Figure 6N) failed to define the relationships of P5C accumulation, FAD depletion, ROS change, mitochondrial dynamics and sperm quality. A better model needs to be suggested.

From all the new data and revisions we made to this manuscript we have come up with a model that clarifies the relationships between FAD, *alh-6*, and mitochondrial dynamics on sperm function. See Figure 7 for model.

\[Editors' note: what follows is the authors' response to the second round of review.\]

> Reviewer \#2:
>
> \[...\]
>
> 1\) It is interesting that loss of ALH-6, but not PRDH-1 which uses FAD as cofactor, caused reduction of FAD levels. What are the possible biochemical explanations? Can this be experimentally tested?

This is an important point. Our current and previous work has shown that the first step of proline catabolism (PRDH-1) is not reduced despite the loss of the second step in the pathway (ALH-6).

The changes in FAD are unlikely to be a result of the loss of any single enzyme. Instead, in the *alh-6* mutant background, the accumulation of P5C results in a stress response that includes the upregulation of many FAD binding enzymes as shown in Figure 3. It is this overall transcriptional signature that drives the phenotypes associated with *alh-6* loss. In other words, it is the downstream response to the loss of *alh-6*, not simply the loss of this enzyme, that is causal for this reduction in FAD. We have added additional text to explicitly state this hypothesis in the subsection "Transcriptional signatures define temporal phenotypes of *alh-6* mutant animals".

> 2\) The authors performed germline-specific RNAi to inactivate alh-6 and FAD synthesis genes, which induced sperm defects as in alh-6 mutant animals. In addition, expression of ALH-6 in the germline rescued the sperm defects. Thus, the conclusion is drawn that the effects of alh-6 loss on sperm function are cell autonomous. This seems not to be sufficient. Will overexpression of ALH-6 in somatic tissues, e.g., the intestine, rescue the sperm defect in alh-6 mutants?

The reviewer is correct that our model of cell autonomous function is based on our findings that the reduction of *alh-6* expression specifically in the germline recapitulating the *alh-6* mutant sperm defects when combined with expression of wildtype *alh-6* specifically in the germline can rescues the defects of *alh-6* mutants.

Our previous work has demonstrated that ALH-6 function in the soma is important for animal lifespan; specifically, loss of *alh-6* can impact muscle, intestine, and neuronal tissues. Although expression only in somatic tissues (i.e. germline restricted) is technically challenging (to our knowledge there doesn't exist a "soma-specific" promoter), we address the reviewer's comment by utilizing a germline RNAi deficient strain from Carolyn Philips and Gary Ruvkun's labs, GR1948 -- *mut-14(mg464);smut-1(tm1301)* V. This strain is competent for RNAi in somatic tissues, but not the germline (PMID: 24684932). In this strain, RNAi of *alh-6* only in the soma does not phenocopy the *alh-6* mutant sperm activity phenotypes. Thus loss of *alh-6* in somatic tissues does not drive sperm activation defects, but may contribute cell non-autonomously to cell size. This data can now be found in Figure 6---figure supplement 1A-B and further discussed in the subsection "*alh-6* and FAD are cell autonomous regulators of sperm function"

In conclusion, and in contrast to the germline specific experiments reported in the last submission, RNAi of *alh-6* only in the soma fails recapitulate the *alh-6* mutant sperm phenotype.

> Reviewer \#3:
>
> \[...\]
>
> 1\) Though Pronase (a mixture of proteases which cleave any surface protein on the cell) could be used to assess wild type sperm activation, Monensin is a better artificial sperm activation as it can make activated spermatozoa to crawl. At least, the authors need to check at which step mutant sperm failed to activate. The crossing data (in vivo sperm activation in Figure 1F) are inconsistent to the rest mutant sperm activation data.

We thank the reviewer for suggesting the use of Monensin. We have tested Monensin and similar to previous studies we find if to be a poorer activator of spermatids (Ward et al., 1983). Furthermore, it was also shown that spermatids activated by either treatment produces motile spermatozoa (Shakes and Ward, 1989). Nevertheless, we now include our tests of the *alh-6* mutant spermatids with Monensin treatment, which like our previous results with Pronase, display reduced activation compared to WT spermatids. This data can be found in Figure 2---figure supplement 1D and in the subsection "Defects in mitochondrial proline catabolism impact sperm quality".

We now also include the assessment of intermediate stages of spermiogenesis. Our previous assessment was very strict, where the observance of "spikes" and rounded protrusions (Nelson and Ward, 1980; Shakes and Ward, 1989), were both considered not activated. Only the extension of a pseudopod was considered an activated state, noting that the treatment time of 30 min was sufficient for pseudopod formation in \~80% of WT spermatids. We have now further analyzed our data for *alh-6* mutants compared to WT and document the percent of intermediate activation states for both Pronase and Monensin treatments. Intriguingly, there does seem to be a difference in the type of stalled intermediate observed when either Pronase or Monensin is used. While Pronase treatment results in an increase in intermediates with spikes, Monensin treatment results in an increase of protrusions. These new data can be found in Figure 2---figure supplement 1B, C, and E and in the subsection "Defects in mitochondrial proline catabolism impact sperm quality".

We believe that the data in Figure 1G (in vivo sperm activation) are consistent with sperm that are not completely abolished for sperm function, but are partially deficient in activation (note that 60% activate) and are simply smaller. The reduction in sperm activation and smaller size of *alh-6* male sperm may lead to disadvantages in competing against WT hermaphrodite sperm. This impairs, but does not abolish the ability to fertilize the next passing oocyte (increase in WT hermaphrodite self-sperm fertilized progeny in those mated to *alh-6* males) as shown in Figure 1F. However, when not forced to compete against hermaphrodite sperm, *alh-6* mutant sperm are competent for fertilization Figure 1---figure supplement 3A-B. We better explain these result in the subsection "*alh-6* fertility defects are sperm-specific".

> 2\) JC-1 staining (Figure 5A-D) was employed extensively in this study to show the mitochondrial fusion or not. This reviewer suggests confirming that with a GFP-tagged mitochondrial protein such as TOM20 to avoid any bias for imaging collection and analysis.

We thank the reviewer for this comment as it is an important point, which we now explain in text and include additional controls for specificity. JC-1 is the preferred staining method for spermatid mitochondria for several reasons, including:

1\) JC-1 fluorescence (red) is specific for coupled mitochondria with a strong membrane potential (Smiley et al., 1991; Reers et al., 1995, Methods Enzymol.; Di Lisa et al., 1995, J. Physiol.; Cossarizza et al., 1996, Exp. Cell. Res.; Mathur et al., 2000, Cardiovasc. Res.).

2\) We have tested several protein based mitochondria-targeted reporters (made by us and others in the field), but as the reviewer comments above, the transcriptional and translational quiescence of sperm limits the expression of these constructs thus prohibiting their use in quantitative assessments.

Nevertheless, to address the reviewers concern we now also show that treatment with the mitochondrial specific uncoupler Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) abolishes the JC-1 fluorescence in the red channel, which confirms the mitochondria specificity of this dye. We better clarify in text that we use mitochondria with red JC-1 emission for assessment of connectivity of the healthiest mitochondria with strong membrane potential (subsection "Mitochondrial dynamics regulate spermatid function", second paragraph). In addition, we include our data from earlier preliminary studies assessing mitochondrial connectivity with a different mitochondrial specific dye MitoTracker Red (Chen et al., 2003, J. Cell Bio.; Matsuda et al., 2010, J. Cell Bio.; Cottet-Rousselle et al., 2011, Cytometry A.). Although JC-1 is the preferred vital stain, MitoTracker staining results in a similar observation of increased connectivity in *alh-6* mutant sperm mitochondria as compared to wildtype counterpart. Taken together these data confirm the specificity of these dyes in mitochondrial assays as previously established by the field. These new data can be found in Figure 5---figure supplement 1A and C.

> 3\) Figure 1---figure supplement 1D should use a better image instead of the current one.

We have replaced this image.
